We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

Back to rankings

25 hedge funds and large institutions have $26.4M invested in TetraLogic Pharmaceuticals Corporation in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less funds holding

Funds holding: 28 → 25 (-3)

30% less capital invested

Capital invested by funds: $37.7M → $26.4M (-$11.3M)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
4
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$109K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$65.3K
3
OC
Oppenheimer & Co
New York
+$53.6K
4
TH
Timber Hill
Connecticut
+$51.2K
5
Goldman Sachs
Goldman Sachs
New York
+$45.7K

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$189K
2
TC
TFS Capital
Pennsylvania
-$113K
3
PP
Paloma Partners
Connecticut
-$91K
4
Bank of America
Bank of America
North Carolina
-$84K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$60K
Name Holding Trade Value Shares
Change 		Change in
Stake
CV
1
Clarus Ventures
Massachusetts
$19.3M – – –
KCM
2
Kingdon Capital Management
New York
$1.17M – – –
PRCM
3
Pine River Capital Management
Minnesota
$873K – – –
SFM
4
Sphera Funds Management
Israel
$808K -$27K -5,800 -3%
FWC
5
First Washington Corp
Washington
$771K -$42.8K -9,190 -5%
EA
6
Emerald Advisers
Pennsylvania
$728K – – –
Wellington Management Group
7
Wellington Management Group
Massachusetts
$667K – – –
First Eagle Investment Management
8
First Eagle Investment Management
New York
$476K – – –
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$329K -$17.5K -3,747 -5%
HighTower Advisors
10
HighTower Advisors
Illinois
$277K – – –
Morgan Stanley
11
Morgan Stanley
New York
$227K +$109K +23,430 +75%
Goldman Sachs
12
Goldman Sachs
New York
$198K +$45.7K +9,810 +26%
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$149K – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$134K +$792 +170 +0.5%
Deutsche Bank
15
Deutsche Bank
Germany
$58K -$31.5K -6,761 -32%
Vanguard Group
16
Vanguard Group
Pennsylvania
$58K +$65.3K +14,018 New
OC
17
Oppenheimer & Co
New York
$48K +$53.6K +11,500 New
TH
18
Timber Hill
Connecticut
$46K +$51.2K +10,985 New
Northern Trust
19
Northern Trust
Illinois
$44K -$22.6K -4,845 -31%
U
20
UBS
Switzerland
$17K +$5.39K +1,156 +40%
GT
21
Glenmede Trust
Pennsylvania
$16K – – –
TRCT
22
Tower Research Capital (TRC)
New York
$6K +$6.71K +1,441 New
Citigroup
23
Citigroup
New York
$4K +$3.98K +854 New
BIM
24
BlackRock Investment Management
Delaware
$3K – – –
BNP Paribas Financial Markets
25
BNP Paribas Financial Markets
France
$890 -$787 -169 -44%
1
2

TLOG Hedge Fund Activity: Q3 2014 in Review

25 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q3 2014, worth a combined $26.4M — down 30% from $37.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TLOG and 5 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Morgan Stanley, adding an estimated $109K. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $189K sold.

  • 25 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q3 2014, down from 28 in Q2 2014.
  • Funds reported $26.4M of TetraLogic Pharmaceuticals Corporation stock for Q3 2014, down 30% quarter-over-quarter.
  • 5 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q3 2014 and 8 closed out, a net change of -3 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q3 2014 was Morgan Stanley, an estimated $109K added.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q3 2014 was Driehaus Capital Management, an estimated $189K sold.

Based on aggregated 13F filings for Q3 2014.